There has been increasing interest in the interaction of genetic susceptibility and xenobiotic exposures in cancer etiology. Study of geneenvironment interactions may increase our ability to characterize relatively low population risks if a substantial proportion of the population cancer burden is attributed to high risk among a smaller group of genetically susceptible members. Further, these studies may provide insight into the mechanism of carcinogenesis, which can help establish the biologic plausibility of an exposure-cancer relationship. Biologic processes important in tumorigenesis that exhibit substantial interindividual differences may function as susceptibility factors. Potential examples include polymorphic enzymes, which activate and detoxify procarcinogens and carcinogens (e.g., certain P450 enzymes, N-acetyltransferase [NAT21, glutathione S-transferase Ml), and variation in the capacity to repair DNA. Biologic assays are now available to evaluate many of these functions at the DNA and phenotype level and can be readily incorporated into studies of cancer etiology. -Environ Health Perspect 1 03(Suppl 8): 291-295 (1995) 
Introduction
Numerous environmental carcinogens have been identified through epidemiologic study and this knowledge has led directly to approaches to reduce cancer occurrence. This approach has been most successful for relatively potent environmental carcinogens associated with risks of about 2-fold or greater. Because of the observational character of epidemiologic studies, interpretation is problematic when risks are much weaker than this. There is, however, an increasing need to characterize such carcinogens as we attempt to reduce the cancer burden among the general population. Study of gene-environment interactions may increase our ability to characterize relatively low population risks if a substantial proportion of the population cancer burden is attributed to high risk among a smaller group of genetically susceptible members exposed to the compound under study. In addition, these studies may provide insight into the mechanism of carcinogenesis, which can help establish the biologic plausibility of an exposure-cancer relationship.
In this paper, we focus on gene alleles that are common in the population and procarcinogens and carcinogens (e.g., Phase I enzymes, which catalyze oxidation, reduction, and hydrolysis reactions, and Phase II enzymes, which catalyze conjugation and synthetic reactions), and repair DNA. The development of assays to measure these processes and their initial application in epidemiologic studies has been extensively reviewed (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Table 1 includes several examples of these processes, which can be studied at either the DNA level if the genetic basis of the polymorphism has been characterized, or at the phenotypic level using assays that reflect the function of either a single gene product (e.g., N-acetyltransferase, coded by NAT2) (4), or of several possible enzymes (e.g., DNA repair) (16 (17, 18) and aflatoxin (19) . Deficiency in this enzyme is caused by inheriting a homozygous deletion of the GSTMI gene (20) (21) (22) , which is referred to as the null (38) .
An extensive body ofwork has indicated that subjects with the slow N-acetylation phenotype, which is caused by homozygous mutations in the NAT2 gene, are at increased risk for bladder cancer compared with rapid acetylators, particularly among populations with exposure to aromatic amines (4); however, this phenotype does not appear to be a risk factor for bladder cancer in populations exposed only to benzidine (39 (41) . The cancer risk posed by exposure to HAAs in the diet may depend upon the extent to which the compounds are activated by N-oxidation (carried out by CYP1A2) and acetylation (thought to be carried out by NAT2) (42) (43) (44) (45) (46) . Interindividual variability in CYP1A2 activity is known to be partially a result of induction by environmental exposures such as cigarette smoking and dietary exposure to PAHs; however, there also may be a genetic component (7) . Activity of NAT2 and CYP1A2 can be characterized by measuring excreted caffeine metabolites in urine after caffeine consumption, which can distinguish between slow and rapid acetylators and N-oxidizers (47) . Recently, Lang et al. (48) evaluated the risk of HAA intake (using preference for meat doneness as a surrogate) in a case-control study of colon polyps and cancer. The overall risk associated with eating well-done meat was 2.1 (adjusted for age and metabolic phenotypes). Compared with subjects with both slow N-acetylation and slow CYP1A2 activity (slow/slow) who consumed meat cooked rare or medium, subjects with slow/slow phenotypes who ate well-done meat had a 2.1-fold increased risk, while subjects with rapid/rapid phenotypes who ate well-done meat had a 6. (55, 56) ], particularly since there may be subtle exposure/gene interactions, where particular alleles are associated with greater risk of cancer at varying levels of exposure to carcinogens (31,57). These interactions are likely to be missed if adequate attention is not given to exposure assessment.
If the basis of observed interindividual variation in a potential susceptibility factor has been characterized at the DNA level, it can be readily studied using DNA collected from peripheral blood samples, or potentially from less invasive sources of DNA (e.g., buccal swabs, which collect small amounts of exfoliated epithelial cells). If a susceptibility factor has not been characterized at the DNA level, then it is necessary to use an assay that measures the phenotypic expression of that variation. Each assay has its own logistic demands, and consideration must be given to the extent to which disease status may potentially influence such assays. Regardless of which assay is used, reliability and accuracy of assays is critical to any epidemiologic investigation. 
